Genmab
Erik Hopmans is a seasoned professional in the field of lab operations and genomics, currently serving as Senior Manager of Lab Operations at Genmab since January 2020, where responsibilities include overseeing laboratory processes. Previously, Erik held the position of Manager Next-Generation Sequencing at BaseClear BV Leiden from January 2016 to March 2019, focusing on optimizing sequencing services and ensuring data quality. Erik's earlier experience includes a role as a Researcher at Stanford University School of Medicine from March 2011 to May 2015, where contributions were made to the Ji Research Group in developing genetic technologies for understanding tumor evolution in gastrointestinal cancers. Erik began his career as a Research Assistant at VU University Medical Center from 2008 to 2011, analyzing exosome content related to EBV-infected cells. Erik holds a Master of Science in Oncology from Vrije Universiteit Amsterdam and a Bachelor of Science in Biochemistry from HU University of Applied Sciences Utrecht.
This person is not in any teams
This person is not in any offices
Genmab
42 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.